ReviewExpert opinion on pharmacotherapy2008
Immunomodulation and pharmacological strategies in the treatment of graft-versus-host disease.
Review in Expert opinion on pharmacotherapy, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 19 citations in OpenAlex.
- Natural multi-target inhibitors from Adhatoda vasica and Calotropis procera for dermal regeneration.Die Naturwissenschaften · 2026Article
- Bone Marrow Cell Trafficking Analyzed byClinical cancer research : an official journal of the American Association for Cancer Research · 2017Article
- Perspectives on the use of mesenchymal stem cells in vascularized composite allotransplantation.Frontiers in immunology · 2013Article
- Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2rγ(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease.Clinical and experimental immunology · 2011Article
- Stem cells and regenerative medicine: accomplishments to date and future promise.Therapeutic delivery · 2010Review
- The role of photopheresis in the treatment of graft-versus-host disease.Current oncology (Toronto, Ont.) · 2010Article
- Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer.Nature reviews. Cancer · 2010Review
- Microenvironment at tissue injury, a key focus for efficient stem cell therapy: A discussion of mesenchymal stem cells.World journal of stem cells · 2009Article
- New perspectives in human stem cell therapeutic research.BMC medicine · 2009Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
backgroundAllogeneic hematopoietic stem cell transplantation offers great promise for the treatment of a variety of diseases including malignancies and other diseases of hematopoietic origin. However, morbidity and mortality due to graft-versus-host disease (GVHD) remain a major barrier to its application.
objectiveThis review will provide an overview of the pathophysiology of GVHD and discuss the recent advances in GVHD management in both preclinical and clinical studies.
methodsAn extensive literature search on PubMed from 1995 to 2008 was performed. RESULTS/
conclusionThere has been much progress in our understanding of GVHD and finding new means to control acute GVHD. While these approaches hold promise, as yet none has been able to replace the standard methods we may use routinely to decrease the incidence of the condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.